|Mr. Adrian R. Bowers||Chief Financial Officer and Company Sec.||142.06k||N/A||N/A|
|Dr. Timothy Guy St. Pierre B.Sc(Hons), Ph.D.||Chief Scientific Officer||208.43k||N/A||N/A|
|Ms. Melanie Baxter||Marketing Director||182.37k||N/A||N/A|
|Mr. Sander Bangma M.Sc, DipMgt||Gen. Mang.||151.62k||N/A||N/A|
|Ms. Celine Royet Pharm.D.||Quality Assurance and Regulatory Affairs Mang.||111.22k||N/A||N/A|
Resonance Health Limited, a healthcare company, engages in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment worldwide. The companys non-invasive magnetic resonance imaging based products include FerriScan, a technology used in the measurement of liver iron concentration; and HepaFat-Scan, a solution for measuring the volume fraction of fat in liver tissue. It also provides clinical trial services, such as project management, reporting, and data management for pharmaceutical companies. The company is headquartered in Claremont, Australia.
Resonance Health Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.